BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688767 Hangzhou Biotest Biotech
- 43.32
- -0.83-1.88%
Market Closed May 15 15:00 CST
4.62BMarket Cap33.32P/E (TTM)
44.48High43.20Low6.59KlotVolume44.16Open44.15Pre Close28.71MTurnover0.62%Turnover Ratio27.26P/E (Static)106.67MShares44.6052wk High1.91P/B4.62BFloat Cap22.8852wk Low52.98Limit Up106.67MShs Float146.02Historical High35.32Limit Down2.90%Amplitude20.95Historical Low1.30Dividend TTM43.57Avg Price3.72KlotAsk3.00%Div YieldTTM100Lot Size2.34KlotBid
Hangzhou Biotest Biotech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -7.83%1.63B | -16.59%1.59B | -13.71%1.61B | -13.64%1.57B | -6.84%1.77B | -1.68%1.91B | 4.53%1.87B | 5.58%1.81B | -6.07%1.9B | 41.84%1.94B |
| Transactional financial assets | ---- | --60.26M | --1M | --100M | ---- | --0 | ---- | ---- | -72.17%102.29M | -72.27%100.06M |
| Notes receivable and accounts receivable | 10.78%67.09M | 57.48%97.46M | 21.90%83.19M | 26.67%68.53M | 15.26%60.57M | 59.41%61.89M | 1.54%68.24M | -31.51%54.1M | -62.24%52.55M | -73.57%38.82M |
| -Accounts receivable | 10.78%67.09M | 57.48%97.46M | 21.90%83.19M | 26.67%68.53M | 15.26%60.57M | 59.41%61.89M | 1.54%68.24M | -31.51%54.1M | -62.24%52.55M | -73.57%38.82M |
| Other receivables (including interest and dividends) | -54.46%1.54M | 52.60%4.27M | -70.90%1.48M | 1,014.18%44.34M | 90.99%3.39M | 74.59%2.8M | -68.88%5.09M | -4.43%3.98M | -78.39%1.78M | -80.75%1.6M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Other receivable | ---- | 52.60%4.27M | ---- | 1,014.18%44.34M | ---- | 74.59%2.8M | ---- | -4.43%3.98M | ---- | -80.75%1.6M |
| Advance payment | 153.89%4.98M | 31.41%1.72M | -85.04%1.54M | -84.25%1.27M | -78.11%1.96M | -70.47%1.31M | -16.89%10.32M | 5.34%8.08M | -52.09%8.96M | -32.95%4.43M |
| Inventories | -7.85%75.12M | -26.10%73.4M | -32.50%76.26M | -32.04%80.46M | -41.77%81.51M | -26.53%99.32M | -44.61%112.98M | -32.18%118.4M | -31.81%139.98M | -4.59%135.2M |
| Non-current assets due within one year | ---- | ---- | ---- | --0 | ---- | --10M | ---- | ---- | ---- | ---- |
| Other current assets | 654.67%44.23M | 1,127.42%49.85M | 743.63%61.35M | -90.62%1.88M | -62.44%5.86M | -73.24%4.06M | --7.27M | 57.95%20.09M | --15.6M | 2,426.58%15.18M |
| Total current assets | -5.14%1.82B | -10.01%1.88B | -11.35%1.83B | -7.70%1.86B | -13.42%1.92B | -6.64%2.09B | -15.94%2.07B | -17.69%2.02B | -19.60%2.22B | 9.97%2.24B |
| Non Current assets | ||||||||||
| Investment real estate | -11.72%4.29M | -11.92%4.34M | 19.30%4.73M | 17.25%4.8M | 17.24%4.86M | 17.66%4.93M | 49.26%3.96M | 51.35%4.09M | 50.87%4.14M | 49.71%4.19M |
| Fixed assets | ---- | 45.79%321.58M | ---- | 63.25%378.17M | ---- | -3.41%220.57M | ---- | -6.24%231.64M | ---- | 1.82%228.37M |
| Constru in process | ---- | 119.96%87.23M | ---- | 1,143.40%49.94M | ---- | 302.60%39.65M | ---- | -7.47%4.02M | ---- | --9.85M |
| Intangible assets | 32.11%273.96M | 31.84%275.16M | -3.01%204.31M | -3.03%205.8M | -3.14%207.37M | -2.34%208.71M | -1.47%210.65M | 1.20%212.23M | 958.33%214.09M | 950.20%213.71M |
| Long deferred expense | ---- | ---- | -80.48%26.78K | -67.12%54.47K | -55.75%81.34K | -49.15%108.27K | -43.82%137.19K | -35.40%165.68K | -31.12%183.82K | -27.18%212.92K |
| Deferred tax assets | -22.78%11.42M | -18.32%11.8M | -8.64%10.29M | -1.01%12.93M | 21.06%14.79M | 9.77%14.44M | 248.86%11.26M | 271.45%13.06M | 3,902.13%12.22M | 337.49%13.16M |
| Usufruct assets | ---- | --0 | -99.40%21.98K | -98.75%61.98K | -88.44%693.21K | -79.11%1.35M | -34.52%3.65M | -15.97%4.94M | -2.29%5.99M | -4.13%6.46M |
| Other non current assets | 683.26%12.04M | 9,550.72%14.8M | -77.74%4.45M | -93.17%2.76M | -96.19%1.54M | -99.62%153.38K | -56.62%20M | -19.98%40.4M | -74.03%40.37M | -71.45%40.35M |
| Total non current assets | 10.42%723.2M | 46.97%724.21M | 43.40%694.83M | 28.67%656.89M | 27.76%654.98M | -4.56%492.76M | -7.56%484.55M | -2.56%510.54M | 20.59%512.69M | 29.46%516.3M |
| Total assets | -1.18%2.54B | 0.87%2.6B | -0.96%2.53B | -0.36%2.52B | -5.68%2.57B | -6.25%2.58B | -14.47%2.55B | -15.02%2.53B | -14.23%2.73B | 13.16%2.75B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 208.86%1.07M | -25.18%440.52K | 66.30%299.03K | -5.33%522.44K | -38.22%347.56K | 68.69%588.77K | -39.06%179.82K | 168.56%551.87K | 44.23%562.59K | -93.81%349.03K |
| Notes payable and accounts payable | -25.00%42.61M | -3.26%56.45M | 16.54%59.44M | 19.37%60.21M | -25.51%56.81M | -34.23%58.35M | -76.72%51.01M | -84.02%50.44M | -81.88%76.27M | -60.45%88.72M |
| -Accounts payable | -25.00%42.61M | -3.26%56.45M | 16.54%59.44M | 19.37%60.21M | -25.51%56.81M | -34.23%58.35M | -76.72%51.01M | -84.02%50.44M | -81.88%76.27M | -60.45%88.72M |
| Contract liabilities | -70.99%12.95M | -84.32%7.39M | 7.16%46.68M | -7.33%41.53M | -1.98%44.66M | 5.53%47.16M | -10.56%43.56M | 10.61%44.81M | 78.10%45.56M | 140.82%44.68M |
| Salaries payable | -23.90%7.73M | -13.43%15.25M | 71.25%14.17M | 49.11%12.28M | 29.77%10.16M | 0.92%17.61M | -43.96%8.27M | -44.85%8.23M | -58.97%7.83M | -28.23%17.45M |
| Taxs payable | -48.65%2.77M | 44.48%4.54M | -81.97%2.05M | -52.54%5.25M | -11.78%5.39M | -67.21%3.14M | -25.42%11.37M | -80.13%11.06M | -94.24%6.11M | -76.73%9.57M |
| Other payable (including interest and dividends) | 89.11%41.16M | 380.95%94.37M | 336.95%16.95M | 389.82%19.83M | 414.96%21.77M | 316.35%19.62M | 625.13%3.88M | 713.13%4.05M | 759.05%4.23M | 319.38%4.71M |
| -Dividend payable | ---- | --53.21M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 109.77%41.16M | ---- | 389.82%19.83M | ---- | 316.35%19.62M | ---- | 713.13%4.05M | ---- | 319.38%4.71M |
| Non current liabilities due within one year | ---- | --0 | -83.47%445.28K | -67.77%1.13M | -63.38%1.79M | -51.99%2.45M | 3.92%2.69M | 43.81%3.5M | 115.87%4.89M | 123.73%5.1M |
| Other current liabilities | 127.11%461.8K | -63.29%185.86K | 104.87%268.03K | 125.06%204.95K | -43.82%203.34K | 4.88%506.26K | -57.12%130.83K | -70.16%91.06K | 4.73%361.95K | 181.37%482.71K |
| Total current liabilities | -22.93%108.76M | 19.54%178.62M | 15.86%140.3M | 14.84%140.96M | -3.21%141.12M | -12.66%149.43M | -59.85%121.1M | -71.47%122.74M | -74.65%145.8M | -46.13%171.08M |
| Current liabilities | ||||||||||
| Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.43M |
| Deferred tax liabilities | ---- | --0 | ---- | -23.67%708.33K | -32.60%708.33K | -39.00%708.33K | --840.88K | --927.99K | --1.05M | --1.16M |
| Long term deferred income | -5.22%10.75M | 28.57%11.17M | 18.57%10.65M | 19.03%11M | 82.55%11.34M | 35.10%8.69M | 35.39%8.99M | 34.77%9.24M | 401.49%6.21M | 414.54%6.43M |
| Lease liabilities | ---- | ---- | ---- | ---- | ---- | ---- | -85.36%456.23K | -67.90%1.14M | -56.34%1.73M | -51.80%2.19M |
| Total non current liabilities | -10.79%10.75M | 18.88%11.17M | 3.61%10.65M | 3.49%11.7M | 33.90%12.05M | -48.40%9.4M | 5.44%10.28M | 8.56%11.31M | 72.63%9M | 213.99%18.21M |
| Total liabilities | -21.98%119.51M | 19.50%189.79M | 14.90%150.96M | 13.88%152.66M | -1.05%153.17M | -16.10%158.82M | -57.80%131.38M | -69.58%134.05M | -73.32%154.8M | -41.46%189.29M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M | 0.00%106.67M |
| Capital reserve funds | -2.30%794.6M | -2.81%790.45M | -0.20%813.33M | -0.20%813.33M | -0.20%813.33M | -0.20%813.33M | 0.00%814.94M | 0.00%814.94M | 0.00%814.94M | 0.00%814.94M |
| Surplus reserve funds | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M | 0.00%53.33M |
| Retained profit | 0.12%1.5B | 2.24%1.49B | 1.43%1.46B | 2.37%1.45B | -6.28%1.5B | -8.08%1.46B | -14.99%1.44B | -9.28%1.41B | -1.66%1.6B | 40.09%1.59B |
| Less:Treasury stock | -41.78%31.61M | 114.09%31.61M | --57.94M | --56.93M | --54.29M | --14.76M | ---- | ---- | ---- | ---- |
| Other composite income | 1,067.14%1.02M | 363.97%939.57K | -203.67%-2.2M | -74.69%566.69K | -105.73%-105.76K | -129.45%-355.94K | 0.08%2.12M | 70.78%2.24M | 167.79%1.85M | 72.31%1.21M |
| Shareholders equity without minority interests | 0.28%2.42B | -0.24%2.41B | -1.79%2.38B | -1.12%2.36B | -6.15%2.42B | -5.70%2.42B | -9.51%2.42B | -5.66%2.39B | -0.99%2.57B | 21.55%2.56B |
| Minority interests | -66.93%1.79M | -47.87%2.87M | -22.38%2.99M | -19.43%3.78M | 661.40%5.41M | 430.67%5.51M | 108.10%3.85M | 207.01%4.69M | -66.27%711.17K | -1.31%1.04M |
| Total shareholder equity | 0.13%2.42B | -0.35%2.41B | -1.82%2.38B | -1.15%2.37B | -5.96%2.42B | -5.52%2.42B | -9.43%2.42B | -5.54%2.39B | -1.05%2.57B | 21.54%2.56B |
| Total liabilityies and equity | -1.18%2.54B | 0.87%2.6B | -0.96%2.53B | -0.36%2.52B | -5.68%2.57B | -6.25%2.58B | -14.47%2.55B | -15.02%2.53B | -14.23%2.73B | 13.16%2.75B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.